Krishna Institute of Medical Sciences Limited — PPTs, 03-08-2026: Investor Presentation

Krishna Institute of Medical Sciences (KIMS) delivered strong operational performance for Q1 FY27. Total Revenue surged to ₹1,195.9 Cr, a 36.1% year-on-year (YoY) increase. EBITDA also grew by 20.1% YoY to ₹239.8 Cr. However, Profit After Tax (PAT) declined by 56.0% YoY to ₹37.4 Cr, and Basic EPS was ₹1.04. Average Revenue Per Occupied Bed (ARPOB) rose 9.7% YoY to ₹47,200, though overall occupancy was 49.0%, a slight dip, likely due to significant capacity additions.

KIMS continues its expansion strategy, adding over 1,300 beds through greenfield projects, acquisitions, and O&M opportunities. Strategic doctor partnerships and a focus on high-quality, affordable care remain key growth drivers, aiming for regional market leadership.

Recent developments include adding 787 beds in Kondapur and 208 beds in Palakkad. Several units achieved clinical milestones: Kannur launched Gastro Interventional Radiology and performed North Malabar’s first Craniosynostosis surgery. Palakkad secured a transplant license and completed its first Renal Transplant. Vizag QNRI established a comprehensive Oncology Center of Excellence. The company's outlook emphasizes sustained performance and driving long-term growth through these strategic levers.